Daily Care and Protection Before Transplant
At a Glance
Before stem cell transplant, children with Cernunnos-XLF deficiency need careful infection prevention, avoidance of unnecessary ionizing radiation, nutrition and developmental support, and irradiated cellular blood products when transfusions are needed.
While a stem cell transplant is the primary goal for treating the immune system, the time leading up to it requires a focus on two things: keeping your child safe from infections and protecting their cells from further damage. Because your child’s body cannot repair DNA breaks normally, daily care is different than it is for other children [1][2].
Preventing Infections
Because your child lacks fully functional T-cells and B-cells, pre-transplant management focuses on providing artificial protection.
- Antibody Replacement (IVIG/SCIG): Most children receive infusions of Immunoglobulin G (IgG), which are collected from healthy donors [3]. This supplies passive antibodies to fight some common bacteria and viruses, though it does not replace the missing T-cell function and cannot prevent every infection.
- Prophylactic Antimicrobials: Your child will likely take daily medications to prevent specific, dangerous infections. This often includes protection against a type of pneumonia called Pneumocystis jirovecii pneumonia (PJP) (formerly PCP) and preventative medicines for fungal or viral infections [3][4].
- Protective Isolation: Depending on your child’s immune function, your team will recommend individualized infection-prevention measures. This often includes evidence-based hand hygiene, avoiding crowds or sick contacts, and ensuring household members receive necessary non-live vaccines [5][4].
Managing Ionizing Radiation
One of the most critical parts of managing Cernunnos-XLF deficiency is minimizing exposure to ionizing radiation, such as X-rays and CT scans [6].
In a healthy person, the small amount of DNA damage from an X-ray is easily fixed. In your child, the cells are highly radiosensitive and struggle to repair the damage [7].
- Use Alternatives: Avoid unnecessary or elective ionizing radiation. Whenever clinically suitable, doctors should use alternatives like ultrasound or MRI [6].
- Balance Risks: If an urgent diagnostic scan is truly life-saving (for example, to diagnose a severe lung infection or bleeding), it should not be withheld. The clinical benefit outweighs the radiation risk. Always balance these decisions with the radiology and immunology specialists [7][6].
Supporting Growth and Development
Because the genetic defect affects more than just the immune system, your child needs a multidisciplinary team.
- Nutrition and Growth: Many children struggle with failure to thrive [2]. A specialized nutritionist can help create a high-calorie plan to support weight gain, which is crucial for staying strong before a transplant [8].
- Neurology and Development: The microcephaly associated with this condition can sometimes lead to developmental delays [9]. A pediatric neurologist and developmental specialists can monitor milestones and provide early intervention [2].
- Hematology: Your child’s blood counts will be monitored closely. Some children develop bone marrow failure or changes in their blood cells that need to be addressed before they head into a transplant [10][11].
Safe Transfusions
If your child ever needs a blood transfusion, cellular blood components (like red blood cells and platelets) MUST be irradiated [5]. This process inactivates any donor T-cells that could otherwise attack your child’s body (Transfusion-Associated Graft-Versus-Host Disease).
Leukoreduction reduces white blood cells but does not replace the need for irradiation. (Note: Plasma and cryoprecipitate are handled differently). Work with your team to establish a medical alert for the blood bank, ensuring they know to provide CMV-safe and irradiated cellular products when needed.
Common questions in this guide
What infection protection does a child with Cernunnos-XLF deficiency need before transplant?
Why are X-rays and CT scans limited in Cernunnos-XLF deficiency?
Why do red blood cells and platelets need to be irradiated?
How can we support a child’s growth and development before transplant?
Does my child need special guidance about live vaccines?
Get notified when new evidence is published on Cernunnos-XLF deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Severe immunodeficiency spectrum associated with NHEJ1 gene mutation: Cernunnos/XLF deficiency
Navarro AM, Mantilla G, Fernández JA, et al.
Biomedica : revista del Instituto Nacional de Salud 2024; (44(Sp. 2)):16-21 doi:10.7705/biomedica.7414.
PMID: 39836852 - 2
Expanding the clinical spectrum of Cernunnos/XLF deficiency: a literature review of a rare cause of severe combined immunodeficiency including a novel case.
Kabadayı G, Atay Ö, Baysal Bakır D, et al.
BMC immunology 2025; (26(1)):89 doi:10.1186/s12865-025-00774-9.
PMID: 41225329 - 3
Cernunnos defect in an Iranian patient with T- B+ NK+ severe combined immunodeficiency: A case report and review of the literature.
Jamee M, Khakbazan Fard N, Fallah S, et al.
Molecular genetics & genomic medicine 2022; (10(8)):e1990 doi:10.1002/mgg3.1990.
PMID: 35656589 - 4
Hematopoietic Cell Transplantation for Severe Combined Immunodeficiency Patients: a Japanese Retrospective Study.
Miyamoto S, Umeda K, Kurata M, et al.
Journal of clinical immunology 2021; (41(8)):1865-1877 doi:10.1007/s10875-021-01112-5.
PMID: 34448087 - 5
Severe Combined Immunodeficiency: A Review for Neonatal Clinicians.
Michniacki TF, Seth D, Secord E
NeoReviews 2019; (20(6)):e326-e335 doi:10.1542/neo.20-6-e326.
PMID: 31261096 - 6
Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency.
Strand J, Gul KA, Erichsen HC, et al.
Frontiers in immunology 2020; (11()):1417 doi:10.3389/fimmu.2020.01417.
PMID: 32754152 - 7
Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?
Cowan MJ, Gennery AR
The Journal of allergy and clinical immunology 2015; (136(5)):1178-85.
PMID: 26055221 - 8
Novel NHEJ1 pathogenic variant linked to severe combined immunodeficiency, microcephaly, and abnormal T and B cell receptor repertoires.
Frizinsky S, Rechavi E, Barel O, et al.
Frontiers in pediatrics 2022; (10()):883173 doi:10.3389/fped.2022.883173.
PMID: 35967585 - 9
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.
Slack J, Albert MH, Balashov D, et al.
The Journal of allergy and clinical immunology 2018; (141(1)):322-328.e10 doi:10.1016/j.jaci.2017.02.036.
PMID: 28392333 - 10
NHEJ1 Splice Variants Associated With Bone Marrow Failure and Hematologic Malignancy.
Weinstock NI, Applegate C, Peng L, et al.
Pediatric blood & cancer 2025; (72(9)):e31884 doi:10.1002/pbc.31884.
PMID: 40580024 - 11
Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor.
Poyer F, Jimenez Heredia R, Novak W, et al.
Frontiers in immunology 2022; (13()):869047 doi:10.3389/fimmu.2022.869047.
PMID: 35812385
This page explains daily infection, radiation, growth, and transfusion precautions for children with Cernunnos-XLF deficiency. It is for informational purposes only, does not constitute medical advice, and cannot replace guidance from your child’s immunology, hematology, and transplant team.